Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction - Results of the CHARM low-left ventricular ejection fraction trials

Young, J. et al. (2004) Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction - Results of the CHARM low-left ventricular ejection fraction trials. Circulation, 110, pp. 2618-2626. (doi:10.1161/01.CIR.0000146819.43235.A9)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McMurray, Professor John
Authors: Young, J., Dunlap, M., Pfeffer, M., Probstfield, J., Cohen-Solal, A., Dietz, R., Granger, C., Hradec, J., Kuch, J., McKelvie, R., McMurray, J., Michelson, E., Olofsson, B., Ostergren, J., Held, P., Solomon, S., Yusuf, S., Swedberg, K., and Comm, C.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences
Journal Name:Circulation

University Staff: Request a correction | Enlighten Editors: Update this record